BiologicalDrug
Muzastotug clinical trials
Also written ADG126.
Keep track of what changes. Save the muzastotug studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- ADG126
- 2
Studies by the year they started
3 studies that test it; most in 2020 (1)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 1
Hoffmann-La Roche (1) · Adagene Inc (1) · National University Hospital, Singapore (1)
Often tested with
Tested in the same studies.
Atezolizumab (1) · Bevacizumab (1) · Tiragolumab (1) · Tocilizumab (1) · Amezalpat (1) · Tobemstomig (1) · Anti-LILRB2 Monoclonal Antibody IO-108 (1) · Imdatifan (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses muzastotug is read from its arms, and is right about nine times in ten.
Testing it · 3
- Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal CancerRecruitingPhase 2National University Hospital, SingaporeNCT06846268Written as ADG126
- A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)Active, not recruitingPhase 1/2Hoffmann-La RocheNCT04524871Written as ADG126
- ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid TumorsCompletedPhase 1/2Adagene IncNCT04645069Written as ADG126 Mono
Given in every arm · 4 — muzastotug is usual care beside what is tested
- Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal CancerNot yet recruitingPhase 1City of Hope Medical CenterNCT07363408Written as Muzastotug
- A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsRecruitingPhase 1Incyte CorporationNCT05836324Written as ADG126
- A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid TumorsRecruitingPhase 1/2SanofiNCT05584670Written as ADG126
- ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid TumorsRecruitingPhase 1/2Adagene IncNCT05405595Written as ADG126
Codes
What other systems call muzastotug · ClinicalTrials.gg INT014891
- UNII (FDA) 4L1XJF3HGLMUZASTOTUGOne source FDA
- NCI Thesaurus C179276MuzastotugOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 4L1XJF3HGL | MUZASTOTUG | One source FDA |
| NCI Thesaurus | C179276 | Muzastotug | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.